Researchers have found rare naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses.
/PRNewswire/ FibroBiologics, a clinical-stage company developing fibroblast cell-based therapeutics for chronic diseases, today introduced its scientific.
Preeminent scientists join FibroBiologics to provide input for the growing clinical pipeline of cell therapies HOUSTON, Dec. 15, 2021 /PRNewswire/ FibroBiologics, a clinical-stage
While most available COVID-19 vaccines target the virus' spike protein, variants including Delta and Omicron have mutations that affect this protein, making them harder for immune cells to detect.